Fig 1.
Map showing the evaluation units and study sites in Nagpur district, Maharashtra, India.
EU-1 Evaluation Unit 1; EU-2 Evaluation Unit 2. Base layer of map: http://www.diva-gis.org/Data. License information: https://www.diva-gis.org/docs/DIVA-GIS_manual_7.pdf. ArcGIS Software: https://www.arcgis.com.
Fig 2.
Box plot of Mf prevalence in sentinel and spot-check sites in Nagpur (2004–2015) [5].
——: WHO threshold Mf prevalence.
Fig 3.
Comparison of age-distribution of samples in the coverage evaluation survey (CES) with (3A) Census population- Female; (3B) Census population- Male.
Fig 4.
Estimated Survey coverage by gender in EU-2, Nagpur.
Blue dash: Reported coverage. Red dash: WHO target coverage threshold.
Table 1.
Area-wise surveyed coverage in EU-2, Nagpur.
Table 2.
Reasons for non-receipt and non-consumption of drugs (N = 500).